Found: 17
Select item for more details and to access through your institution.
Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study.
- Published in:
- Allergy, 2021, v. 76, n. 12, p. 3814, doi. 10.1111/all.15064
- By:
- Publication type:
- Article
EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
- Published in:
- Allergy, 2020, v. 75, n. 12, p. 3287, doi. 10.1111/all.14492
- By:
- Publication type:
- Article
Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 294, doi. 10.1111/cea.14442
- By:
- Publication type:
- Article
IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 11, p. 1222, doi. 10.1111/cea.14384
- By:
- Publication type:
- Article
Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 5, p. 582, doi. 10.1111/cea.14296
- By:
- Publication type:
- Article
Ocular surface disease is common in moderate‐to‐severe atopic dermatitis patients.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 6, p. 801, doi. 10.1111/cea.14127
- By:
- Publication type:
- Article
Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment.
- Published in:
- Clinical & Experimental Allergy, 2019, v. 49, n. 12, p. 1641, doi. 10.1111/cea.13495
- By:
- Publication type:
- Article
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 3, p. 327, doi. 10.1093/bjd/ljad159
- By:
- Publication type:
- Article
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2018, v. 9, n. 9, p. 159, doi. 10.1177/2040622318773686
- By:
- Publication type:
- Article
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.5243
- By:
- Publication type:
- Article
Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.1128
- By:
- Publication type:
- Article
Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.3978
- By:
- Publication type:
- Article
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 10, p. 1, doi. 10.2340/00015555-3886
- By:
- Publication type:
- Article
Two‐year drug survival of dupilumab in a large cohort of difficult‐to‐treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.
- Published in:
- Allergy, 2020, v. 75, n. 9, p. 2376, doi. 10.1111/all.14324
- By:
- Publication type:
- Article
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.
- Published in:
- Allergy, 2020, v. 75, n. 1, p. 116, doi. 10.1111/all.14080
- By:
- Publication type:
- Article
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry.
- Published in:
- Pediatric Allergy & Immunology, 2022, v. 33, n. 12, p. 1, doi. 10.1111/pai.13887
- By:
- Publication type:
- Article
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 11, p. 1240, doi. 10.1001/jamadermatol.2023.3849
- By:
- Publication type:
- Article